Literature DB >> 25970088

Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis.

Peter Benn1, Antoni Borrell2, Rossa W K Chiu3, Howard Cuckle4, Lorraine Dugoff5, Brigitte Faas6, Susan Gross7, Tianhua Huang8, Joann Johnson9, Ron Maymon10, Mary Norton11, Anthony Odibo12, Peter Schielen13, Kevin Spencer14, Dave Wright15, Yuval Yaron16.   

Abstract

Mesh：

Year:  2015        PMID： 25970088     DOI： 10.1002/pd.4608

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN： 0197-3851            Impact factor:   3.050


× No keyword cloud information.
  57 in total

1.  "This lifetime commitment": Public conceptions of disability and noninvasive prenatal genetic screening.

Authors:  Rosemary J Steinbach; Megan Allyse; Marsha Michie; Emily Y Liu; Mildred K Cho
Journal:  Am J Med Genet A       Date:  2015-11-14       Impact factor: 2.802

2.  Genetic Counselors' Perspectives About Cell-Free DNA: Experiences, Challenges, and Expectations for Obstetricians.

Authors:  Patricia K Agatisa; Mary Beth Mercer; Marissa Coleridge; Ruth M Farrell
Journal:  J Genet Couns       Date:  2018-06-27       Impact factor: 2.537

Review 3.  Noninvasive prenatal testing for aneuploidy using cell-free DNA - New implications for maternal health.

Authors:  Lisa Hui
Journal:  Obstet Med       Date:  2016-06-07

4.  Impact of the increased adoption of prenatal cfDNA screening on non-profit patient advocacy organizations in the United States.

Authors:  Stephanie Meredith; Christopher Kaposy; Victoria J Miller; Megan Allyse; Subhashini Chandrasekharan; Marsha Michie
Journal:  Prenat Diagn       Date:  2016-07-18       Impact factor: 3.050

Review 5.  Screening for fetal chromosomal and subchromosomal disorders.

Authors:  Sarah Harris; Dallas Reed; Neeta L Vora
Journal:  Semin Fetal Neonatal Med       Date:  2017-11-08       Impact factor: 3.926

Review 6.  Cost-effectiveness of cell-free DNA in maternal blood testing for prenatal detection of trisomy 21, 18 and 13: a systematic review.

Authors:  Lidia García-Pérez; Renata Linertová; Margarita Álvarez-de-la-Rosa; Juan Carlos Bayón; Iñaki Imaz-Iglesia; Jorge Ferrer-Rodríguez; Pedro Serrano-Aguilar
Journal:  Eur J Health Econ       Date:  2017-12-16

Review 7.  Pre- and post-test genetic counseling for chromosomal and Mendelian disorders.

Authors:  Jill Fonda Allen; Katie Stoll; Barbara A Bernhardt
Journal:  Semin Perinatol       Date:  2015-12-21       Impact factor: 3.300

8.  The Integration of Noninvasive Prenatal Screening into the Existing Prenatal Paradigm: a Survey of Current Genetic Counseling Practice.

Authors:  Emily Suskin; Laura Hercher; Kathleen Erskine Aaron; Komal Bajaj
Journal:  J Genet Couns       Date:  2016-02-15       Impact factor: 2.537

Review 9.  Cell-Free DNA Screening: Complexities and Challenges of Clinical Implementation.

Authors:  Matthew R Grace; Emily Hardisty; Sarah K Dotters-Katz; Neeta L Vora; Jeffrey A Kuller
Journal:  Obstet Gynecol Surv       Date:  2016-08       Impact factor: 2.347

10.  Spanish- and English-Speaking Pregnant Women's Views on cfDNA and Other Prenatal Screening: Practical and Ethical Reflections.

Authors:  Erin Floyd; Megan A Allyse; Marsha Michie
Journal:  J Genet Couns       Date:  2016-01-07       Impact factor: 2.537
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.